From Wikidoc - Reading time: 2 min
|
WikiDoc Resources for TAC regimen |
|
Articles |
|---|
|
Most recent articles on TAC regimen Most cited articles on TAC regimen |
|
Media |
|
Powerpoint slides on TAC regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on TAC regimen at Clinical Trials.gov Clinical Trials on TAC regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on TAC regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on TAC regimen Discussion groups on TAC regimen Patient Handouts on TAC regimen Directions to Hospitals Treating TAC regimen Risk calculators and risk factors for TAC regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for TAC regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:TAC; TAC Regimen; TAC regimen; Taxotere-Adriamycin-Cytoxan Regimen
TAC regimen refers to a regimen consisting of docetaxel (taxotere), doxorubicin and cyclophosphamide used in the adjuvant setting for the treatment of breast cancer.[1][2]
TDocetaxel (Taxotere)
ADoxorubicin (Adriamycin)
CCyclophosphamide